期刊
NEUROSCIENCE LETTERS
卷 465, 期 1, 页码 16-20出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2009.08.075
关键词
Area postrema; Cisplatin; Emesis; Vagus; Ferret
资金
- Merck Research Laboratories
The anti-cancer chemotherapeutic agent cisplatin induces an acute (similar to 24 h) and delayed (similar to 24-72 h+) emetic response in humans; whereas the mechanism mediating the acute phase has been characterised, the delayed phase is relatively poorly understood. We have used nerve lesions (abdominal vagus, VX; greater splanchnic nerve, GSNX) and area postrema ablation (APX) in the ferret model of cisplatin (5 mg/kg, i.p.) delayed emesis and demonstrated that VX and VX + GSNX did not significantly modify the delayed emetic response (24-72 h), which consisted of 276.0 +/- 62.8 retches + vomits (R + V) in sham-operated ferrets and 167.2 +/- 34.0 R + V and 214.8 +/- 40.2 R + V, in the VX and VX + GSNX groups, respectively. APX virtually abolished the delayed phase of emesis and sham-operated ferrets had 93.0 +/- 22.9 R + V whilst only 6.0 +/- 3.6 R + V (p = 0.009) were observed in APX animals. These data suggest that, in contrast to the acute emetic response triggered by cisplatin, the delayed phase does not rely on abdominal visceral afferents but is mediated via the area postrema. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据